FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1915288020> ?p ?o ?g. }

• W1915288020 endingPage "20211" @default.
• W1915288020 startingPage "20195" @default.
• W1915288020 abstract "Asthma is a common chronic pulmonary inflammatory disease, featured with mucus hyper-secretion in the airway. Recent studies found that glucagon like peptide-1 (GLP-1) analogs, including liraglutide and exenatide, possessed a potent anti-inflammatory property through a protein kinase A (PKA)-dependent signaling pathway. Therefore, the aim of current study was to investigate the value of GLP-1 analog therapy liraglutide in airway inflammation and mucus secretion in a murine model of ovalbumin (OVA)-induced asthma, and its underlying molecular mechanism. In our study, BALB/c mice were sensitized and challenged by OVA to induce chronic asthma. Pathological alterations, the number of cells and the content of inflammatory mediators in bronchoalveolar lavage fluid (BALF), and mucus secretion were observed and measured. In addition, the mRNA and protein expression of E-selectin and MUC5AC were analyzed by qPCR and Western blotting. Then, the phosphorylation of PKA and nuclear factor-κB (NF-κB) p65 were also measured by Western blotting. Further, NF-κB p65 DNA binding activity was detected by ELISA. OVA-induced airway inflammation, airway mucus hyper-secretion, the up-regulation of E-selectin and MUC5AC were remarkably inhibited by GLP-1 in mice (all p < 0.01). Then, we also found that OVA-reduced phosphorylation of PKA, and OVA-enhanced NF-κB p65 activation and NF-κB p65 DNA binding activity were markedly improved by GLP-1 (all p < 0.01). Furthermore, our data also figured out that these effects of GLP-1 were largely abrogated by the PKA inhibitor H-89 (all p < 0.01). Taken together, our results suggest that OVA-induced asthma were potently ameliorated by GLP-1 possibly through a PKA-dependent inactivation of NF-κB in mice, indicating that GLP-1 analogs may be considered an effective and safe drug for the potential treatment of asthma in the future." @default.
• W1915288020 created "2016-06-24" @default.
• W1915288020 creator A5006876375 @default.
• W1915288020 creator A5027301633 @default.
• W1915288020 creator A5043443793 @default.
• W1915288020 creator A5045380919 @default.
• W1915288020 date "2015-08-26" @default.
• W1915288020 modified "2023-10-16" @default.
• W1915288020 title "Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice" @default.
• W1915288020 cites W136609552 @default.
• W1915288020 cites W1557078354 @default.
• W1915288020 cites W1584197284 @default.
• W1915288020 cites W1942040918 @default.
• W1915288020 cites W1967150171 @default.
• W1915288020 cites W1972876739 @default.
• W1915288020 cites W1975393873 @default.
• W1915288020 cites W1980300193 @default.
• W1915288020 cites W1986549410 @default.
• W1915288020 cites W1989511200 @default.
• W1915288020 cites W1994449362 @default.
• W1915288020 cites W1997332398 @default.
• W1915288020 cites W2004145580 @default.
• W1915288020 cites W2005088542 @default.
• W1915288020 cites W2008697831 @default.
• W1915288020 cites W2010750037 @default.
• W1915288020 cites W2011048258 @default.
• W1915288020 cites W2011601530 @default.
• W1915288020 cites W2013557350 @default.
• W1915288020 cites W2030588576 @default.
• W1915288020 cites W2035998566 @default.
• W1915288020 cites W2037058123 @default.
• W1915288020 cites W2050735967 @default.
• W1915288020 cites W2053029072 @default.
• W1915288020 cites W2053786608 @default.
• W1915288020 cites W2057930810 @default.
• W1915288020 cites W2057946435 @default.
• W1915288020 cites W2058299128 @default.
• W1915288020 cites W2059572472 @default.
• W1915288020 cites W2068776590 @default.
• W1915288020 cites W2068938067 @default.
• W1915288020 cites W2078128383 @default.
• W1915288020 cites W2085673153 @default.
• W1915288020 cites W2089492050 @default.
• W1915288020 cites W2092833954 @default.
• W1915288020 cites W2092973313 @default.
• W1915288020 cites W2094189191 @default.
• W1915288020 cites W2095266991 @default.
• W1915288020 cites W2097140177 @default.
• W1915288020 cites W2101286472 @default.
• W1915288020 cites W2109887220 @default.
• W1915288020 cites W2113012453 @default.
• W1915288020 cites W2115110969 @default.
• W1915288020 cites W2131055445 @default.
• W1915288020 cites W2137713697 @default.
• W1915288020 cites W2142097676 @default.
• W1915288020 cites W2146951173 @default.
• W1915288020 cites W2150237271 @default.
• W1915288020 cites W2151284052 @default.
• W1915288020 cites W2161872363 @default.
• W1915288020 cites W2161957478 @default.
• W1915288020 cites W2163138242 @default.
• W1915288020 cites W2165144921 @default.
• W1915288020 cites W2321992706 @default.
• W1915288020 cites W2413100710 @default.
• W1915288020 cites W4250640314 @default.
• W1915288020 doi "https://doi.org/10.3390/ijms160920195" @default.
• W1915288020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4613197" @default.
• W1915288020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26343632" @default.
• W1915288020 hasPublicationYear "2015" @default.
• W1915288020 type Work @default.
• W1915288020 sameAs 1915288020 @default.
• W1915288020 citedByCount "68" @default.
• W1915288020 countsByYear W19152880202016 @default.
• W1915288020 countsByYear W19152880202017 @default.
• W1915288020 countsByYear W19152880202018 @default.
• W1915288020 countsByYear W19152880202019 @default.
• W1915288020 countsByYear W19152880202020 @default.
• W1915288020 countsByYear W19152880202021 @default.
• W1915288020 countsByYear W19152880202022 @default.
• W1915288020 countsByYear W19152880202023 @default.
• W1915288020 crossrefType "journal-article" @default.
• W1915288020 hasAuthorship W1915288020A5006876375 @default.
• W1915288020 hasAuthorship W1915288020A5027301633 @default.
• W1915288020 hasAuthorship W1915288020A5043443793 @default.
• W1915288020 hasAuthorship W1915288020A5045380919 @default.
• W1915288020 hasBestOaLocation W19152880201 @default.
• W1915288020 hasConcept C11960822 @default.
• W1915288020 hasConcept C126322002 @default.
• W1915288020 hasConcept C134018914 @default.
• W1915288020 hasConcept C184235292 @default.
• W1915288020 hasConcept C185592680 @default.
• W1915288020 hasConcept C18903297 @default.
• W1915288020 hasConcept C203014093 @default.
• W1915288020 hasConcept C2776914184 @default.
• W1915288020 hasConcept C2776946954 @default.
• W1915288020 hasConcept C2777312293 @default.
• W1915288020 hasConcept C2777730290 @default.
• W1915288020 hasConcept C49039625 @default.

• next